Tomorrow Investor

Menu
Tomorrow Investor
Food & Health
fileName-sanofi-s-type-1-diabetes-drug-wins-eu-panel-recommendation-1763128922048
Food & Health
Sanofi's Type 1 Diabetes Drug Wins EU Panel Recommendation
Nov. 14, 2025
Dateline: PARIS, November 14, 2025 – Sanofi (SNY.PA) gained European regulatory backing for its first-of-its-kind diabetes drug that delays disease onset in high-risk patients. The recommendation positions Sanofi to capture market share in a previously untreatable patient population, potentially...
➜
fileName-bristol-myers-j-j-halt-heart-drug-trial-after-interim-analysis-shows-poor-results-1763129107913
Food & Health
Bristol Myers, J&J Halt Heart Drug Trial After Interim Analysis Shows Poor Results
Nov. 14, 2025
Dateline: NEW YORK, November 14, 2025 – Bristol Myers Squibb (BMY) and Johnson & Johnson (JNJ)...
fileName-biontech-reassures-investors-as-pfizer-partnership-remains-intact-1763042625343
Food & Health
BioNTech Reassures Investors as Pfizer Partnership Remains Intact
Nov. 13, 2025
Dateline: FRANKFURT, November 13, 2024 – BioNTech (BNTX) confirmed its collaboration with Pfizer...
fileName-tyson-foods-forecasts-annual-revenue-rise-as-chicken-demand-offsets-beef-woes-1762783557000
Food & Health
Tyson Foods Forecasts Annual Revenue Rise as Chicken Demand Offsets Beef Woes
Nov. 10, 2025
Dateline: SPRINGDALE, Ark., Nov 10, 2025 – Tyson Foods (TSN) forecasts fiscal 2026 revenue to rise...
fileName-treehouse-foods-surges-20-on-2-9-billion-buyout-deal-1762783732614
Food & Health
TreeHouse Foods Surges 20% on 2.9 Billion Buyout Deal
Nov. 10, 2025
Dateline: NEW YORK, November 10, 2025 – TreeHouse Foods (THS.N) surged 20% after agreeing to be...
fileName-gilead-s-trodelvy-fails-late-stage-breast-cancer-study-shares-fall-1762524143523
Food & Health
Gilead's Trodelvy Fails Late-Stage Breast Cancer Study, Shares Fall
Nov. 7, 2025
FOSTER CITY, November 7, 2024 – Gilead Sciences’ (GILD.O) breast cancer drug Trodelvy failed...
fileName-j-j-gains-fda-approval-for-caplyta-depression-add-on-therapy-1762438127034
Food & Health
J&J Gains FDA Approval for Caplyta Depression Add-On Therapy
Nov. 6, 2025
NEW YORK, November 6, 2025 – Johnson & Johnson (JNJ) received FDA approval to expand Caplyta...

Trending

fileName-sanofi-s-type-1-diabetes-drug-wins-eu-panel-recommendation-1763128922048
Food & Health
Sanofi's Type 1 Diabetes Drug Wins EU Panel Recommendation
Nov. 14, 2025
fileName-walmart-ceo-doug-mcmillon-to-retire-names-insider-john-furner-as-successor-1763129019471
Finance
Walmart CEO Doug McMillon to Retire, Names Insider John Furner as Successor
Nov. 14, 2025
fileName-bristol-myers-j-j-halt-heart-drug-trial-after-interim-analysis-shows-poor-results-1763129107913
Food & Health
Bristol Myers, J&J Halt Heart Drug Trial After Interim Analysis Shows Poor Results
Nov. 14, 2025

CATEGORIES

Categories

SIGNUP TO OUR NEWSLETTER

Subscribe

Get breaking market insights directly to your inbox